Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Sherie, Smith"'
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
Inhaled antibiotics are commonly used to treat persistent airway infection with Pseudomonas aeruginosa that contributes to lung damage in people with cystic fibrosis. Current guidelines recommend inhaled tobramycin for individuals with cystic fibrosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f77ac598f77f210906634372a361e8b
https://pubmed.ncbi.nlm.nih.gov/29607494
https://pubmed.ncbi.nlm.nih.gov/29607494
Autor:
Sophie Herbert, Sherie Smith, Katie Gathercole, Christabella Ng, Nicola Rowbotham, Gwyneth Davies, Sarah J Collins, Zoe Elliott, Lorna Allen, Alan Smyth
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction Relieving gastrointestinal (GI) symptoms was identified as a ‘top ten’ priority by our James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF). We conducted an online survey to find out more about the effect of GI sy
Externí odkaz:
https://doaj.org/article/bfa05a56b9fa4e60beb38b3347b63029
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate whether digital technology can effectively predict pulmonary exacerbations to allow earlier intervention and improved health outcomes without increasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7075b03f2a0864d426c3091b981ec8
https://doi.org/10.1002/14651858.cd014606.pub2
https://doi.org/10.1002/14651858.cd014606.pub2
Publikováno v:
Cochrane Database Syst Rev
BACKGROUND: Respiratory disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and many different therapies are used by people with CF in the management of respiratory problems. Bronchodilator therapy is used to relieve symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bdf09c4cb7d6b286a429543fcbb37ea
https://doi.org/10.1002/14651858.cd013666.pub2
https://doi.org/10.1002/14651858.cd013666.pub2
Autor:
Alan R. Smyth, Sherie Smith, André Schultz, Richard Norman, Christopher C Blyth, Tom Snelling, Steve Webb, Charlie McLeod, Jamie Wood
Publikováno v:
Journal of Cystic Fibrosis. 19:858-867
Background There is no consensus about which outcomes should be evaluated in studies of pulmonary exacerbations in people with cystic fibrosis (CF). Outcomes used for evaluation should be meaningful; that is, they should capture how people feel, func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f708a14647c6c57a869dd93552b696cf
https://doi.org/10.1016/j.jcf.2020.08.015
https://doi.org/10.1016/j.jcf.2020.08.015
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Autor:
Zoe C Elliot, Alan R. Smyth, Paul Leighton, Katie Gathercole, Alistair Ja Duff, Nicola J. Rowbotham, O.C. Rayner, Tracey Daniels, Suja Chandran, Edward F. Nash, Sherie Smith, Sophie Herbert, Gwyneth Davies
Publikováno v:
Journal of Cystic Fibrosis. 19:499-502
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: "What are effective ways of simplifying the treatment burden of people with CF?" We aimed to summarise the lived exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa6c8482a48418eceb30d9a802e5461
https://doi.org/10.1016/j.jcf.2019.10.025
https://doi.org/10.1016/j.jcf.2019.10.025
Publikováno v:
Paediatric Respiratory Reviews. 36:109-111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b70d7a2f0bfc30498d253d1cf20323b
https://doi.org/10.1016/j.prrv.2020.09.004
https://doi.org/10.1016/j.prrv.2020.09.004
Publikováno v:
Expert Review of Respiratory Medicine. 13:425-434
Introduction: Cystic fibrosis is a life-limiting genetic condition characterized by recurrent pulmonary infection. Acquisition of infection can occur from environmental reservoirs, person-to-person transmission and from the healthcare environment. Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c132b904d6e71fb1f4f296f9300117
https://doi.org/10.1080/17476348.2019.1595594
https://doi.org/10.1080/17476348.2019.1595594
Autor:
Z.C. Elliott, Nicola J. Rowbotham, Paul Leighton, Alan R. Smyth, Sophie Herbert, Patrick Wilson, Sherie Smith, Alistair J.A. Duff
Publikováno v:
Thorax. 77(3)
Reducing treatment burden in cystic fibrosis (CF) is the top research priority for patients and clinicians. Difficulty accessing medication is one aspect of treatment burden. We investigated this with an online survey available globally for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37558de9ad1e410996a08f3ee5a5e8e1
https://pubmed.ncbi.nlm.nih.gov/34556553
https://pubmed.ncbi.nlm.nih.gov/34556553
Autor:
Christopher C Blyth, Allison Tong, Steve Webb, Sherie Smith, Alan R. Smyth, Jamie Wood, Richard Norman, Charlie McLeod, Tom Snelling, André Schultz
Publikováno v:
European respiratory review : an official journal of the European Respiratory Society. 30(160)
There is no consensus on how best to measure responses to interventions among children and adults with cystic fibrosis (CF). We have systematically reviewed and summarised the characteristics and measurement properties of tests and tools that have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0fa4d4e5592bceb05fa46b0381b8e0
https://pubmed.ncbi.nlm.nih.gov/33980667
https://pubmed.ncbi.nlm.nih.gov/33980667